Please use this identifier to cite or link to this item: https://hdl.handle.net/10419/233679 
Year of Publication: 
2021
Citation: 
[Journal:] Health Economics [ISSN:] 1099-1050 [Volume:] 30 [Issue:] 3 [Publisher:] Wiley [Place:] Hoboken, NJ [Year:] 2021 [Pages:] 585-602
Publisher: 
Wiley, Hoboken, NJ
Abstract: 
Many OECD countries have replaced per-diem hospital reimbursement with lump sum payments by diagnosis-related groups. This study analyzes hospital responses to a large-scale refinement of reimbursement practices in Germany on January 1, 2006, in which regulating authorities introduce reimbursements by treatment intensity in the market for stroke disorder. We find that the share of admissions receiving high-intensity treatments jumps by approximately 7 percentage points around the turn of the year. At the same time, a decrease in the average clinical severity of patients receiving these high-intensity treatments reveals that the marginal high-intensity treated patient in 2006 might be less appropriate for high-intensity treatments compared to 2005. We do not find accompanying (short-term) changes in the quality of care, such as decreases in in-hospital mortality.
Subjects: 
DRGs
hospital reimbursement
hospital supply
clinical pathways
Persistent Identifier of the first edition: 
Creative Commons License: 
cc-by-nc-nd Logo
Document Type: 
Article
Document Version: 
Published Version

Files in This Item:
File
Size
778.66 kB





Items in EconStor are protected by copyright, with all rights reserved, unless otherwise indicated.